EdgarLookup

AUBURN NATIONAL BANCORPORATION, INC — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that AUBURN NATIONAL BANCORPORATION, INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $12.35M Mar 17, 2026
FY2025 Dec 31, 2024 $10.81M Mar 17, 2026
FY2024 Dec 31, 2023 $11.90M Mar 11, 2025
FY2023 Dec 31, 2022 $10.98M Mar 14, 2024
FY2022 Dec 31, 2021 $12.32M Mar 17, 2023
FY2021 Dec 31, 2020 $9.73M Mar 8, 2022
FY2020 Dec 31, 2019 $10.85M Mar 9, 2021
FY2019 Dec 31, 2018 $12.14M Mar 6, 2020
FY2018 Dec 31, 2017 $9.40M Mar 12, 2019
FY2017 Dec 31, 2016 $10.49M Mar 13, 2018

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.49M Mar 17, 2026
FY2025 Dec 31, 2024 $2.09M Mar 17, 2026
FY2024 Dec 31, 2023 $418.0K Mar 11, 2025
FY2023 Dec 31, 2022 $7.05M Mar 14, 2024
FY2022 Dec 31, 2021 $20.18M Mar 17, 2023

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.02B Mar 17, 2026
FY2025 Dec 31, 2024 $977.32M Mar 17, 2026
FY2024 Dec 31, 2023 $975.26M Mar 11, 2025
FY2023 Dec 31, 2022 $1.02B Mar 14, 2024
FY2022 Dec 31, 2021 $1.11B Mar 17, 2023
FY2021 Dec 31, 2020 $956.60M Mar 8, 2022
FY2020 Dec 31, 2019 $827.88M Mar 9, 2021
FY2019 Dec 31, 2018 $818.08M Mar 6, 2020
FY2018 Dec 31, 2017 $853.38M Mar 12, 2019
FY2017 Dec 31, 2016 $831.94M Mar 13, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $926.74M Mar 17, 2026
FY2025 Dec 31, 2024 $899.03M Mar 17, 2026
FY2024 Dec 31, 2023 $898.75M Mar 11, 2025
FY2023 Dec 31, 2022 $955.85M Mar 14, 2024
FY2022 Dec 31, 2021 $1.00B Mar 17, 2023
FY2021 Dec 31, 2020 $848.91M Mar 8, 2022
FY2020 Dec 31, 2019 $729.55M Mar 9, 2021
FY2019 Dec 31, 2018 $729.02M Mar 6, 2020
FY2018 Dec 31, 2017 $766.48M Mar 12, 2019
FY2017 Dec 31, 2016 $749.77M Mar 13, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $119.24M Mar 17, 2026
FY2025 Dec 31, 2024 $115.76M Mar 17, 2026
FY2024 Dec 31, 2023 $113.40M Mar 11, 2025
FY2023 Dec 31, 2022 $116.60M Mar 14, 2024
FY2022 Dec 31, 2021 $109.97M Mar 17, 2023
FY2021 Dec 31, 2020 $105.62M Mar 8, 2022
FY2020 Dec 31, 2019 $101.80M Mar 9, 2021
FY2019 Dec 31, 2018 $95.64M Mar 6, 2020
FY2018 Dec 31, 2017 $90.30M Mar 12, 2019
FY2017 Dec 31, 2016 $85.72M Mar 13, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2012 Dec 31, 2012 $18.76M Mar 22, 2013
FY2012 Dec 31, 2011 $12.40M Mar 22, 2013
FY2011 Dec 31, 2010 $11.43M Mar 26, 2012

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2018 Dec 31, 2017 $3.22M Mar 12, 2019
FY2017 Dec 31, 2016 $3.22M Mar 13, 2018
FY2016 Dec 31, 2015 $7.22M Mar 3, 2017
FY2015 Dec 31, 2014 $12.22M Mar 10, 2016
FY2014 Dec 31, 2013 $12.22M Mar 24, 2015
FY2013 Dec 31, 2012 $47.22M Mar 24, 2014
FY2012 Dec 31, 2011 $85.31M Mar 22, 2013
FY2011 Dec 31, 2010 $93.33M Mar 26, 2012

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 2 Mar 17, 2026
FY2025 Dec 31, 2024 1 Mar 17, 2026
FY2024 Dec 31, 2023 0 Mar 11, 2025
FY2023 Dec 31, 2022 2 Mar 14, 2024
FY2022 Dec 31, 2021 2 Mar 17, 2023

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 2 Mar 17, 2026
FY2025 Dec 31, 2024 1 Mar 17, 2026

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 3.49M Mar 17, 2026
FY2025 Dec 31, 2024 3.49M Mar 17, 2026
FY2025 Dec 31, 2023 3.49M Mar 17, 2026
FY2024 Dec 31, 2022 3.50M Mar 11, 2025
FY2023 Dec 31, 2021 3.52M Mar 14, 2024
FY2022 Dec 31, 2020 3.57M Mar 17, 2023
FY2021 Dec 31, 2019 3.57M Mar 8, 2022
FY2020 Dec 31, 2018 3.64M Mar 9, 2021
FY2019 Dec 31, 2017 3.64M Mar 6, 2020
FY2018 Dec 31, 2016 3.96M Mar 12, 2019